The tumor microenvironment supports the development of tumor associated macrophages (TAMs) which are characterized by an immune-suppressive phenotype. TAMs can facilitate the proliferation of tumor cells and are able to suppress anti-tumor immune responses within the tumor microenvironment, making them a highly attractive target for the development of innovative cancer immunotherapies.

Download this poster to discover:

• A suite of assays that can be used to test novel compound activity
• How to select the most effective therapeutic compounds for further investigation
• Identification of the most appropriate tumor type for clinical development